The DEEP project has received research funding from the European Union under the 7th Framework Programme

News

Italy: First Patients are successfully completing and concluding DEEP-2 study

Marzo 8, 2015
|
Comments off
|

Significant progresses have been made in patients’ enrolment in the DEEP-2 study (multicentre, randomized, open label, controlled trial aimed at comparing the efficacy of deferiprone and deferasirox in paediatric patients).

So far, 8 Italian centres have already started the patients’ enrollment: recently the Azienda Ospedaliera di Padova […]

Share
Read more →

Rare diseases and Paediatrics – Article on the goals of CVBF as DEEP Coordinator

Marzo 1, 2015
|
Comments off
|

On March 1st, 2015 the national newspaper Corriere della Sera published, on its issue “Speciale Salute”, an article entirely dedicated to CVBF, its contributions and goals in the fields of Rare diseases and Paediatrics.

The article, entitled “Rare diseases and Paediatrics: the goals of the Consorzio per Valutazioni […]

Share
Read more →

DEEP – “Towards new frontiers of paediatric clinical research”

Febbraio 27, 2015
|
Comments off
|

Even the “Corriere Sociale,” the section of the Corriere della Sera dedicated to issues of volunteering and Third Sector, has published on February 27, 2015, an article on the commitment of CVBF and its activities in the field of rare diseases and paediatrics. The article emphasizes […]

Share
Read more →

DEEP 2 – first patients enrolled in Padua!

Gennaio 20, 2015
|
Comments off
|

On the 2nd of January 2015, the Azienda Ospedaliera di Padova (AOSP) has enrolled its first patient in the DEEP-2 study (multicentre, randomized, open label, controlled trial aimed at comparing the efficacy of deferiprone and deferasirox in paediatric patients). Other two paediatric patients have been included in […]

Share
Read more →